GE
58
-2
O
20
-8
DAL
70
-4
HCA
44
7
CAT
51
7
MU
46
-4
SIG
38
-5
LOW
42
2
NEM
57
2
SWKS
46
-5
L
45
2
STT
54
12
LUV
45
-3
WMT
67
-3
DOW
39
5
SEE
45
4
COF
44
2
V
50
8
DG
2
-14
GILD
38
-11
GE
58
-2
O
20
-8
DAL
70
-4
HCA
44
7
CAT
51
7
MU
46
-4
SIG
38
-5
LOW
42
2
NEM
57
2
SWKS
46
-5
L
45
2
STT
54
12
LUV
45
-3
WMT
67
-3
DOW
39
5
SEE
45
4
COF
44
2
V
50
8
DG
2
-14
GILD
38
-11
Financhill
Back

Biomarin Pharmaceutical Stock Predictions

Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings

Analyze Any Stock Free
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
$63.83
Seasonality Move:
2.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free

Biomarin Pharmaceutical Stock Forecast

  • Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 14.2% based on the past 25 years of stock performance.
  • Biomarin Pharmaceutical has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
  • Is Biomarin Pharmaceutical Stock Undervalued?
    The current Biomarin Pharmaceutical [BMRN] share price is $66.99. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Biomarin Pharmaceutical Stock Go Up Next Year?

  • Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 14.2% based on the past 25 years of stock performance.

Biomarin Pharmaceutical Stock Rating

Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical overpriced?

  • Biomarin Pharmaceutical has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%

Biomarin Pharmaceutical Stock Price History

Is BMRN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com

52-Week Data

52-Week High:
96.60
52-Week Low:
61.15

Prediction Charts

Market Cap:
12.8B
Price in USD:
66.99
Volume:
1.1M
Beta:
0.87

Technical Analysis

SMA50:
65.83
SMA100:
71.47
SMA200:
77.73
52-Wk Change:
-28.22%

Stock Predictions

  • Is Biomarin Pharmaceutical stock public?
    Yes, Biomarin Pharmaceutical is a publicly traded company.
  • What is the Biomarin Pharmaceutical stock quote today?
    The Biomarin Pharmaceutical stock price is 66.99 USD today.
  • How to buy Biomarin Pharmaceutical stock online?
    You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-20 64.90 65.69 66.27 64.07
Dec-23 65.07 66.27 66.46 64.65
Dec-24 65.96 66.63 67.09 65.25
Dec-26 66.30 67.02 67.10 66.21
Dec-27 66.89 66.89 67.47 66.38
Dec-30 66.30 65.45 66.46 65.24
Dec-31 65.74 65.73 66.16 65.33
Jan-2 65.97 66.49 66.74 65.86
Jan-3 66.56 66.83 67.50 66.44
Jan-6 66.93 67.07 67.75 66.70
Jan-7 67.07 67.90 68.85 66.91
Jan-8 67.90 68.38 69.70 67.43
Jan-10 67.26 67.38 67.94 66.01
Jan-13 67.58 66.99 67.58 65.95

Biomarin Pharmaceutical Earnings

Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biomarin Pharmaceutical Forecast Revenue Growth

Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.

* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.